CYCN
NASDAQ · Biotechnology
Cyclerion Therapeutics Inc
$1.47
+0.03 (+1.73%)
Open$1.48
Previous Close$1.45
Day High$1.48
Day Low$1.46
52W High$3.79
52W Low$1.03
Volume—
Avg Volume32.9K
Market Cap6.08M
P/E Ratio—
EPS$-0.76
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,381.0% upside
Current
$1.47
$1.47
Target
$21.77
$21.77
$14.42
$21.77 avg
$30.48
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.21M | 4.03M | 1.11M |
| Net Income | -4,908,220 | -5,537,668 | -131,808 |
| Profit Margin | -152.9% | -145.2% | -11.8% |
| EBITDA | -5,242,146 | -6,242,996 | -161,572 |
| Free Cash Flow | — | — | -153,109 |
| Rev Growth | -20.2% | -20.2% | +14.6% |
| Debt/Equity | — | — | 0.60 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $217.49 | +2.05% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $351.85 | +0.82% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $139.37 | +2.22% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $446.54 | +0.76% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $772.64 | +3.12% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $330.87 | +4.68% | 139.7 | 43.84B |